shutterstock_761873647_-motortion-films
motortion films / Shutterstock.com
6 August 2020PharmaMuireann Bolger

Webinar: antibody patents in Europe and beyond

Antibody patenting can be a minefield for IP practitioners if they lack the most up-to-date knowledge about the best way to approach a patent application. Antibody experts and European patent attorneys Tom Leonard, Alison Care and Dave Wortley from law firm  Kilburn & Strode joined WIPR group editor Tom Phillips for a  webinar on the latest developments in antibody patenting yesterday, August 5.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Pharma
8 October 2026   Following ANDA litigation over Tafinlar earlier this year, the Swiss multinational has sued the generics maker over its proposed version of Mekinist, asserting patents that cover both the composition and treatment regimen.
Pharma
8 October 2026   Rival Halozyme secures a major patent victory against the pharma giant, blocking the subcutaneous version of its blockbuster cancer drug Keytruda across eight countries as MSD faces mounting pressure ahead of key patent expirations.
Pharma
6 October 2026   Day one of the UK patent trial over blockbuster drug Jardiance put a lack of biological data, disputed evidence of testing and the limits of scientific prediction under the spotlight.